Última Hora: "Novo modelo da Autoeuropa faz disparar produção automóvel em Portugal - Expresso" Thu, 14 Dec 2017 16:56:00 GMT    "SEF abre concurso para admitir 100 inspetores - Diário de Notícias - Lisboa" Thu, 14 Dec 2017 15:04:00 GMT    "BES: Tribunal declara nula acusação de BdP contra Salgado e Amílcar Pires - Público.pt" Thu, 14 Dec 2017 21:16:11 GMT    "Governo PS e os apoios à Raríssimas. Valor manteve-se, não quadruplicou - Observador" Thu, 14 Dec 2017 12:11:41 GMT    "Raríssimas: Jerónimo de Sousa acredita que a "procissão ainda vai no adro" - Diário de Notícias - Lisboa" Thu, 14 Dec 2017 19:33:09 GMT    "Nuno Mota Pinto vai presidir ao Montepio e os restantes administradores deverão sair com Félix Morgado - Expresso" Thu, 14 Dec 2017 20:28:00 GMT   "This RSS feed URL is deprecated" Thu, 14 Dec 2017 21:19:39 GMT    "Uber cobra 12 mil euros por viagem de 20 minutos - Dinheiro Vivo" Thu, 14 Dec 2017 18:18:43 GMT    "Anacom está analisar alterar condições do serviço postal - Jornal de Negócios - Portugal" Thu, 14 Dec 2017 18:29:00 GMT    "Estados Unidos aprovam fim da neutralidade da internet - RTP" Thu, 14 Dec 2017 20:31:00 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
Business Wire (press release)
... (USA), Inc. since September 2016, where he was instrumental in building the U.S. operations to support the company's regulatory and commercial strategy. Prior to joining Santhera U.S., Todd served as Executive Vice President and Chief Commercial ...

e mais »

Difficult Defenses in the Courtroom: December 2017
Healio
Faculty members report the following financial relationships: Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol ...


Global Asthma Medication Market Research:Opportunities by Regions, Types, Applications, Trend Forecast to 2022
MilTech
Asthma Medication Market Segment by Manufacturers: ? Dulera,QVAR,Glaxosmithkline plc,MAP Pharmaceuticals?Inc,Merck & Co. Inc,AstraZeneca plc,Roche Holdings Ltd,Genentech Inc,Sepracor, Inc,Schering-Plough Corp,Sanofi-Aventis,Theravance Inc and many more ...

e mais »

Zacks Small Cap Research (press release)

PULM: Business And Financial Update For Third Quarter 2017
Zacks Small Cap Research (press release)
On November 9, 2017 Pulmatrix (NASDAQ:PULM) announced their third quarter financial results and provided operational highlights. Revenue of $0.3 million was recorded for the quarter which was related to the grant received from the Cystic Fibrosis ...


TechnoPOW (blog)

Desloratadine Market Healthcare, Clinical Reviews, Survey Reports 2017 to 2022
TechnoPOW (blog)
Leading Manufacturers Analysis in Global Desloratadine Market 2017: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt. The Global Desloratadine ...

e mais »

Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors
Business Wire (press release)
Prior to that , he held roles as Executive Vice President and Chief Administrative and Legal Officer at Inspire Pharmaceuticals Inc., where he oversaw all matters related to legal, quality and compliance, corporate development and licensing and ...

e mais »

Novelion Therapeutics Appoints Mark Corrigan, MD to Board of Directors
GlobeNewswire (press release)
Dr. Corrigan was previously president and chief executive officer of Zalicus Inc. Prior to that, he was executive vice president, research & development of Sepracor Inc. (now Sunovion Pharmaceuticals). Prior to joining Sepracor, Dr. Corrigan spent 10 ...

e mais »

Belgium's Ablynx enters the US market
PMLiVE
Ablynx Belgium biopharmaceutical company Ablynx has established a beachhead in the US, setting up a new subsidiary for that market. Ablynx, Inc will be led by newly-appointed general manager Daniel Schneider, who will be based on the east coast. One of ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications
GlobeNewswire (press release)
... Relations and Corporate Communications at HeartWare International, Inc., a leading innovator of less-invasive, miniaturized circulatory support technologies for advanced heart failure, which was acquired by Medtronic plc. Prior to HeartWare, Ms ...

e mais »

Flex Pharma Reports Third Quarter 2017 Financial Results
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ:FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments in Phase 2 randomized, controlled trials for cramps and spasticity associated with severe neurological diseases such as ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
?In partnership with CMO Tom Wessel, my former Sepracor colleague, we are poised to execute on our US Phase 2 development plans.? Tweet this. Flex Pharma, Inc. (NASDAQ: FLKS), focused on developing treatments for cramps and spasms associated with ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Yahoo Finance
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the David H ...

e mais »

Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by Dainippon ...

e mais »

Dainippon Sumitomo Pharma to Acquire Sepracor for US $23.00 Per Share in an All-Cash Tender Offer Valued at ...
FierceBiotech
OSAKA, Japan & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Dainippon Sumitomo Pharma Co., Ltd. ("DSP", TSE: 4506) and Sepracor Inc. ("Sepracor", Nasdaq: SEPR) today announced that they have entered into a definitive agreement pursuant to which DSP will ...
Drugmaker Sepracor Accepts $2.6B Buyout Offer from Japan's DainipponXconomy

todos os 485 artigos de notícias »

Rewire

Religious Imposition Proponents Find an Ally in the White House
Rewire
The firm's clients between those years included AstraZeneca Pharmaceuticals, Sepracor Inc, and the National Association of Spine Specialists. Another hire, Anna Pilato, is now serving as deputy assistant secretary for external affairs in the agency's ...

Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters